Results 121 to 130 of about 28,866 (196)

Advancements in Preclinical Models for NF2-Related Schwannomatosis Research. [PDF]

Cancers (Basel)
Zhang BS, Lu S, Plotkin SR, Xu L.
europepmc   +1 more source

Combining Brigatinib with mTOR Inhibition to Effectively Treat NF2-SWN-Associated and Sporadic NF2-Deficient Meningiomas. [PDF]

Cancer Res Commun
Chang LS, Oblinger JL, Wu LMN, Miller C, Burns SS.   +4 more
europepmc   +1 more source

Merlin's disappearing act: NF2 loss conjures pancreatic cancer survival in the hostile tumor microenvironment. [PDF]

J Clin Invest
Ferreira S, Attardi LD.
europepmc   +1 more source

Variant Resolution Through RNA Testing and Affected Tissue Analysis in the Neurofibromatoses: A Case Series. [PDF]

Neurol Genet
Schatz KS, Applegate CD, Belzberg AJ, Chen Y, Romo CG, Slobogean B, Blakeley J, Dimachkie MM.   +7 more
europepmc   +1 more source

Single-cell multi-omic techniques highlight the diverse composition and intercellular interactions of the vestibular schwannoma tumor microenvironment. [PDF]

Neurooncol Adv
Pari SS, Pugazenthi S, Kim AH, Patel B.
europepmc   +1 more source

NF2-associated schwannomatosis (NF2): genetics, manifestations, and emerging therapeutic approaches

Trends in Molecular Medicine
Osama Elzaafarany, Daniel Lester, Sepideh Mokhtari, Joseph L. Kissil   +3 more
openaire   +2 more sources

Tumor Control After Radiosurgery in Sporadic and Neurofibromatosis Type 2 Vestibular Schwannomas. [PDF]

Cancer Med
Ji SY, Kim YH, Chang WS, Kang H, Lee JI, Han JH, Kim CY, Kim JH, Roh HW, Hwang JH, Park SH, Koh YC, Cho J, Choi SK, Park CK, Kim SH, Roh TH, Lee SR, Lee SW, Sung SK, Kim MS, Lee WH, Lee SI, Kim SH, Kim SH, Kim KH, Choi JW, Seol HJ, Cho YH, Kim J, Jung HH, Chang JH.   +31 more
europepmc   +1 more source

NF2 Gene Mutation [PDF]

, 2020
openaire   +1 more source

Schwannomatosis tumor modeling: progress and prospects for translational research. [PDF]

J Biol Eng
Madison MS, Xu H, Gonzalez-Vargas Y, Yonk MG, Thompson CM, Haney H, Babbitt D, Du Y, Hirbe AC, Boulis NM, Bai RY, Lei K.   +11 more
europepmc   +1 more source

A cochlea-sparing strategy for non-invasive control of intracranial schwannomas via peripheral irradiation and anti-PD-1 therapy enhanced by STING activation. [PDF]

Theranostics
Yin Z, Lu S, Wu L, Sun Y, Blake DC, Chen J, Landegger LD, Ho W, Xiu B, Jones AP, Muzikansky A, Shih HA, Stankovic KM, Plotkin SR, Xu L.   +14 more
europepmc   +1 more source